{"id":526,"date":"2020-02-12T17:03:56","date_gmt":"2020-02-12T16:03:56","guid":{"rendered":"http:\/\/invivo.partners\/?post_type=portoflio_invivo&#038;p=526"},"modified":"2021-09-02T16:13:40","modified_gmt":"2021-09-02T14:13:40","slug":"arthex-biotech","status":"publish","type":"portoflio_invivo","link":"https:\/\/invivo.partners\/es\/portoflio_invivo\/arthex-biotech\/","title":{"rendered":"Arthex biotech"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">ARTHEx Biotech es una empresa <em>spin-off<\/em> de la <strong>Universitat de Val\u00e8ncia<\/strong>, con una s\u00f3lida experiencia en microRNAs&nbsp;en enfermedades neuromusculares. La empresa se centra en el desarrollo de <strong>tratamientos con ARN <\/strong>contra enfermedades gen\u00e9ticas. El candidato principal, ATX-01, es un tratamiento basado en antimiR contra la <strong>Distrofia Miot\u00f3nica Tipo I.<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>CEO y cofundadora: Dra. Beatriz Llamus\u00ed<\/li><li>Asesor y cofundador: Dr. Rub\u00e9n Artero<\/li><li>Ubicaci\u00f3n: Paterna (Valencia)<\/li><li>Web: <strong><a rel=\"noreferrer noopener\" href=\"https:\/\/arthexbiotech.com\/\" target=\"_blank\">arthexbiotech.com<\/a><\/strong><\/li><\/ul>\n","protected":false},"featured_media":0,"template":"","tipo_portfolio":[507],"class_list":["post-526","portoflio_invivo","type-portoflio_invivo","status-publish","hentry","tipo_portfolio-invivoventures"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Arthex biotech - Invivo Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/invivo.partners\/es\/portoflio_invivo\/arthex-biotech\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arthex biotech - Invivo Partners\" \/>\n<meta property=\"og:description\" content=\"ARTHEx Biotech es una empresa spin-off de la Universitat de Val\u00e8ncia, con una s\u00f3lida experiencia en microRNAs&nbsp;en enfermedades neuromusculares. La empresa se centra en el desarrollo de tratamientos con ARN contra enfermedades gen\u00e9ticas. El candidato principal, ATX-01, es un tratamiento basado en antimiR contra la Distrofia Miot\u00f3nica Tipo I. CEO y cofundadora: Dra. Beatriz Llamus\u00ed\" \/>\n<meta property=\"og:url\" content=\"https:\/\/invivo.partners\/es\/portoflio_invivo\/arthex-biotech\/\" \/>\n<meta property=\"og:site_name\" content=\"Invivo Partners\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-02T14:13:40+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/invivo.partners\/es\/portoflio_invivo\/arthex-biotech\/\",\"url\":\"https:\/\/invivo.partners\/es\/portoflio_invivo\/arthex-biotech\/\",\"name\":\"Arthex biotech - Invivo Partners\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/#website\"},\"datePublished\":\"2020-02-12T16:03:56+00:00\",\"dateModified\":\"2021-09-02T14:13:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/invivo.partners\/es\/portoflio_invivo\/arthex-biotech\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/invivo.partners\/es\/portoflio_invivo\/arthex-biotech\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/invivo.partners\/es\/portoflio_invivo\/arthex-biotech\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/invivo.partners\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arthex biotech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/invivo.partners\/#website\",\"url\":\"https:\/\/invivo.partners\/\",\"name\":\"Invivo Capital\",\"description\":\"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.\",\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/invivo.partners\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/invivo.partners\/#organization\",\"name\":\"Invivo Capital\",\"url\":\"https:\/\/invivo.partners\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"contentUrl\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Invivo Capital\"},\"image\":{\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Arthex biotech - Invivo Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/invivo.partners\/es\/portoflio_invivo\/arthex-biotech\/","og_locale":"es_ES","og_type":"article","og_title":"Arthex biotech - Invivo Partners","og_description":"ARTHEx Biotech es una empresa spin-off de la Universitat de Val\u00e8ncia, con una s\u00f3lida experiencia en microRNAs&nbsp;en enfermedades neuromusculares. La empresa se centra en el desarrollo de tratamientos con ARN contra enfermedades gen\u00e9ticas. El candidato principal, ATX-01, es un tratamiento basado en antimiR contra la Distrofia Miot\u00f3nica Tipo I. CEO y cofundadora: Dra. Beatriz Llamus\u00ed","og_url":"https:\/\/invivo.partners\/es\/portoflio_invivo\/arthex-biotech\/","og_site_name":"Invivo Partners","article_modified_time":"2021-09-02T14:13:40+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/invivo.partners\/es\/portoflio_invivo\/arthex-biotech\/","url":"https:\/\/invivo.partners\/es\/portoflio_invivo\/arthex-biotech\/","name":"Arthex biotech - Invivo Partners","isPartOf":{"@id":"https:\/\/invivo.partners\/#website"},"datePublished":"2020-02-12T16:03:56+00:00","dateModified":"2021-09-02T14:13:40+00:00","breadcrumb":{"@id":"https:\/\/invivo.partners\/es\/portoflio_invivo\/arthex-biotech\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/invivo.partners\/es\/portoflio_invivo\/arthex-biotech\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/invivo.partners\/es\/portoflio_invivo\/arthex-biotech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/invivo.partners\/es\/"},{"@type":"ListItem","position":2,"name":"Arthex biotech"}]},{"@type":"WebSite","@id":"https:\/\/invivo.partners\/#website","url":"https:\/\/invivo.partners\/","name":"Invivo Capital","description":"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.","publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/invivo.partners\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/invivo.partners\/#organization","name":"Invivo Capital","url":"https:\/\/invivo.partners\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/","url":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","contentUrl":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","width":1200,"height":630,"caption":"Invivo Capital"},"image":{"@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/portoflio_invivo\/526","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/portoflio_invivo"}],"about":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/types\/portoflio_invivo"}],"wp:attachment":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/media?parent=526"}],"wp:term":[{"taxonomy":"tipo_portfolio","embeddable":true,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/tipo_portfolio?post=526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}